Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 12 studies | 63% ± 25% | |
| GABAergic neuron | 9 studies | 50% ± 27% | |
| retinal ganglion cell | 7 studies | 49% ± 21% | |
| interneuron | 6 studies | 54% ± 27% | |
| neuron | 5 studies | 36% ± 14% | |
| granule cell | 4 studies | 79% ± 7% | |
| GABAergic interneuron | 3 studies | 39% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 11 studies | 44% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 80% | 2657.49 | 196 / 245 | 74% | 3.58 | 370 / 502 |
| brain | 88% | 11219.26 | 2336 / 2642 | 64% | 6.24 | 452 / 705 |
| bladder | 86% | 8720.14 | 18 / 21 | 8% | 0.41 | 41 / 504 |
| uterus | 68% | 2234.08 | 116 / 170 | 12% | 0.79 | 53 / 459 |
| intestine | 71% | 6458.76 | 685 / 966 | 3% | 0.09 | 17 / 527 |
| esophagus | 57% | 1747.88 | 821 / 1445 | 3% | 0.07 | 6 / 183 |
| stomach | 15% | 362.16 | 54 / 359 | 8% | 0.24 | 23 / 286 |
| adrenal gland | 0% | 22.66 | 1 / 258 | 10% | 0.60 | 23 / 230 |
| ovary | 4% | 57.59 | 8 / 180 | 4% | 0.16 | 18 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 6% | 0.50 | 11 / 178 |
| lung | 1% | 13.93 | 4 / 578 | 4% | 0.28 | 48 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| kidney | 1% | 8.01 | 1 / 89 | 1% | 0.07 | 8 / 901 |
| thymus | 0% | 0 | 0 / 653 | 2% | 0.08 | 12 / 605 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
| skin | 0% | 0.42 | 1 / 1809 | 1% | 0.06 | 5 / 472 |
| breast | 0% | 0 | 0 / 459 | 1% | 0.03 | 6 / 1118 |
| blood vessel | 0% | 4.14 | 6 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 0% | 4.24 | 1 / 241 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
| heart | 0% | 0.80 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.40 | 1 / 929 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.89 | 1 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008380 | Biological process | RNA splicing |
| GO_0006397 | Biological process | mRNA processing |
| GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
| GO_0007399 | Biological process | nervous system development |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003729 | Molecular function | mRNA binding |
| Gene name | RBFOX3 |
| Protein name | RNA binding fox-1 homolog 3 RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Neuronal nuclei antigen) (NeuN antigen) RNA binding protein fox-1 homolog 3 |
| Synonyms | |
| Description | FUNCTION: Pre-mRNA alternative splicing regulator. Regulates alternative splicing of RBFOX2 to enhance the production of mRNA species that are targeted for nonsense-mediated decay (NMD). . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . FUNCTION: RNA-binding protein that regulates alternative splicing events. . |
| Accessions | K7ESF7 ENST00000584778.5 [A6NFN3-2] A6NFN3 ENST00000693108.1 J3QQZ2 ENST00000582043.5 K7EJX6 A0A8I5KWJ3 ENST00000582880.6 ENST00000582894.5 ENST00000583458.5 ENST00000580508.1 A0A3B3ITL7 J3QRF4 ENST00000648001.1 K7EQK7 ENST00000580155.5 [A6NFN3-1] |
